Indian equity benchmarks opened sharply lower on Tuesday, with the Nifty 50 slipping below the 24,100 mark and the BSE Sensex shedding more than 400 points in early trading.
The broad-based decline reflects mounting pressure from higher crude oil prices and lingering geopolitical concerns that have weighed on investor sentiment across emerging markets.
04% to ₹1,403.30, while Max Healthcare also faced significant downward pressure.
The pharmaceutical sector emerged as the primary drag on the index, with heavy selling across major names.
IndiGo, a key component of the healthcare and aviation-linked trades, fell 2.75% to ₹5,159.
Cipla dropped 2.04% to ₹1,403.30, while Max Healthcare also faced significant downward pressure.
The sector’s weakness underscores the sensitivity of domestic pharma stocks to input cost inflation and global supply chain disruptions linked to energy markets.